Results: Our study indicated that 86 potential plasma proteins may have a substantial causal association with the incidence of 33 hematological tumors, such as BCL2, NFKB1, PARP1, and TNFRSF14. This evidence concerns the gene TNFRSF14 and hematopoietic and lymphoid system neoplasm.